An international, multicenter, prospective study of a prothrombin complex concentrate, Prothromplex Total®, in anticoagulant reversal

Thrombosis Research

Volumn 135, Issue 3, 2015, Pages 485-491

  Altorjay, Áron ^a   Szabó, Éva ^b   Boda, Zoltán ^c   Kramer, Ludwig ^d   Ngo, Leock Y ^e   Engl, Werner ^f   Firth, Clair L ^f   Ahlstrom, Erik R ^e   Gelmont, David M ^e   Pabinger, Ingrid ^g  

^a St George University Teaching Hospital   (Hungary)

^b Veszprem County Hospital   (Hungary)

^c UNIVERSITY OF DEBRECEN   (Hungary)

^d Hietzing Hospital   (Austria)

^e BAXTER HEALTHCARE CORPORATION   (United States)

^f BAXTER INNOVATIONS GMBH   (Austria)

^g MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Anticoagulant reversal; Oral anticoagulant; Prothrombin complex concentrate; Prothromplex total; Vitamin K antagonists

Indexed keywords

ACENOCOUMAROL; ANTIVITAMIN K; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING FACTOR 9 CONCENTRATE; PHENPROCOUMON; PROTHROMBIN; PROTHROMBIN COMPLEX; WARFARIN; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR; HEMOSTATIC AGENT; PROTHROMBIN COMPLEX CONCENTRATES; VITAMIN K GROUP;

ACUTE DISEASE; ACUTE HEART INFARCTION; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN DEFICIENCY; SCREENING; THROMBOSIS; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; CLINICAL TRIAL; HEMORRHAGE; MIDDLE AGED; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BLOOD COAGULATION FACTORS; FEMALE; HEMORRHAGE; HEMOSTATICS; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VITAMIN K;

EID: 84925775021     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2014.12.026     Document Type: Article

References (26)

1. W. Ageno, A.S. Gallus, A. Wittkowsky, M. Crowther, E.M. Hylek, and G. Palareti Oral anticoagulant therapy: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 e44S e88S
2. C. Kearon, E.A. Akl, A.J. Comerota, P. Prandoni, H. Bounameaux, and S.Z. Goldhaber Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 e419S e494S [Online Data Suppl p1-91]
3. L.A. Linkins, P.T. Choi, and J.D. Douketis Clinical Impact of Bleeding in Patients Taking Oral Anticoagulant Therapy for Venous Thromboembolism A Meta-Analysis Ann Intern Med 139 2003 893 900
4. A. Spencer, and R.C. Becker The Prothrombinase Complex: Assembly and Function J Thromb Thrombolysis 4 1997 357 364
5. M. Makris, J.J. van Veen, C.R. Tait, A.D. Mumford, M. Laffan British Committee for Standards in Haematology Guideline on the management of bleeding in patients on antithrombotic agents Br J Haematol 160 2012 35 46 10.1111/bjh.12107 [Link to Publisher's Site]
6. H.A. Tran, S.D. Chunilal, P.L. Harper, E.M. Wood, A.S. Gallus Australasian Society of Thrombosis and Haemostasis (ASTH) An update of consensus guidelines for warfarin reversal Med J Aust 198 2013 198 199
7. G. Evans, R. Luddington, and T. Baglin Beriplex P/N reverses severe warfarin-induced overanticoagulation immediately and completely in patients presenting with major bleeding Br J Haematol 115 2001 998 1001
8. M. Makris, M. Greaves, W.S. Phillips, S. Kitchen, F.R. Rosendaal, and E.F. Preston Emergency oral anticoagulant reversal: The relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy Thromb Haemost 77 1997 477 480
9. C.A. Leissinger, P.M. Blatt, W.K. Hoots, and B. Ewenstein Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature Am J Hematol 83 2008 137 143
10. R. Sarode, T.J. Milling Jr., M.A. Refaai, A. Mangione, A. Schneider, and B.L. Durn Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study Circulation 128 11 Sep 10 2013 1234 1243 10.1161/CIRCULATIONAHA.113.002283 [Epub 2013 Aug 9]
11. J. Ansell, J. Hirsh, L. Poller, H. Bussey, A. Jacobson, and E. Hylek The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 2004 204S 233S
12. T.P. Baglin, D.M. Keeling, H.G. Watson British Committee for Standards in Haematology Guidelines on oral anticoagulation (warfarin): third edition-2005 update Br J Haematol 132 2006 277 285
13. R.I. Baker, P.B. Coughlin, A.S. Gallus, P.L. Harper, H.H. Salem, and E.M. Wood Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis Med J Aust 181 2004 492 497
14. J. Hirsh, V. Fuster, J. Ansell, J.L. Halperin American Heart Association American College of Cardiology Foundation American Heart Association/American College of Cardiology Foundation guide to warfarin therapy Circulation 107 2003 1692 1711
15. C.J. Wiedermann, and I. Stockner Warfarin-induced bleeding complications - clinical presentation and therapeutic options Thromb Res 122 Suppl. 2 2008 S13 S18
16. R. Demeyere, J. Arnout, and P. Strengers Prothrombin complex concentrate versus fresh frozen plasma in patients on oral anticoagulant therapy undergoing cardiac surgery: a randomized study Crit Care 10 Suppl. 1 2006 S97 S98
17. A. Lubetsky, R. Hoffman, R. Zimlichman, A. Eldor, J. Zvi, and V. Kostenko Efficacy and safety of a prothrombin complex concentrate (Octaplex) for rapid reversal of oral anticoagulation Thromb Res 113 2004 371 378
18. R. Lorenz, J. Kienast, U. Otto, M. Kiehl, D. Schreiter, and S. Haertel Successful emergency reversal of phenprocoumon anticoagulation with prothrombin complex concentrate: a prospective clinical study Blood Coagul Fibrinolysis 18 2007 565 570
19. I. Pabinger, B. Brenner, U. Kalina, S. Knaub, A. Nagy, and H. Ostermann Prothrombin complex concentrate (Beriplex® P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial J Thromb Haemost 6 2008 622 631
20. R. Sharples, C. Burnett, P. Murphy, and J.P. Hanley Prospective evaluation of a regional protocol for rapid warfarin reversal in major haemorrhage Br J Haematol 121 Suppl. 1 2003 3 4
21. L. van Aart, H.W. Eijkhout, J.S. Kamphuis, M. Dam, M.E. Schattenkerk, and T.J. Schouten Individual dosing regimen for prothrombin complex concentrate more effective than standard treatment in the reversal of oral anticoagulant therapy: an open, prospective randomized controlled trial Thromb Res 118 2006 313 320
22. D.A. Taberner, J.M. Thomson, and L. Poller Comparison of prothrombin complex concentrate and vitamin K1 in oral anticoagulant reversal Br Med J 2 6027 Jul 10 1976 83 85
23. M. Yasaka, T. Sakata, K. Minematsu, and H. Naritomi Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication Thromb Res 108 1 2002 Oct 1 25 30
24. S.S. Adam, N.S. Key, and C.S. Greenberg D-dimer antigen: current concepts and future prospects Blood 113 13 2009 2878 2887
25. P. Bucciarelli, S.M. Passamonti, E. Biguzzi, F. Gianniello, F. Franchi, and P.M. Mannucci Low borderline plasma levels of antithrombin, protein C and protein S are risk factors for venous thromboembolism J Thromb Haemost 10 9 2012 Sep 1783 1791
26. S.R. Leal-Noval, R. López-Irizo, J. Bautista-Paloma, M. Casado, V. Arellano-Orden, and M. Leal-Romero Efficacy of the prothrombin complex concentrate prothromplex in patients requiring urgent reversal of vitamin K antagonists or presenting with uncontrolled bleeding: a retrospective, single center study Blood Coagul Fibrinolysis 24 8 2013 Dec 862 868